Farmae SpA banner
F

Farmae SpA
MIL:FAR

Watchlist Manager
Farmae SpA
MIL:FAR
Watchlist
Price: 9.36 EUR -3.9% Market Closed
Market Cap: €64.1m

Wall St Price Targets

FAR Price Targets Summary
Farmae SpA

There are no price targets for FAR.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Farmae SpA Competitors:
Price Targets
2697
Guangdong True Health Medical Technology Development Co Ltd
-26% Downside
TB
Triboo SpA
21% Upside

Revenue
Forecast

41% / Year
Past Growth
16% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
41% / Year
Past Growth
16% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 1 year, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 3 years is 16%.

Gross Profit
Forecast

38% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
38% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Farmae SpA

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Farmae SpA

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is FAR's stock price target?
Not Available

FAR does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Farmae SpA?
Projected CAGR
16%

Over the last 1 year, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 3 years is 16%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett